Viatris stock trades at 16.63 euros ahead of earnings
Published on 11/03/2026 at 13:43 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSQuarterly results are next
- Viatris is scheduled to release its third-quarter 2026 financial results on November 5.
- The company has also announced a tender offer to acquire Pacira BioSciences.
Viatris stock traded at 16.63 euros on Lang & Schwarz at 13:37 Berlin time on Tuesday, November 3, 2026. The quote is a midday indication ahead of the company's scheduled third-quarter results.
Quarterly results are next
Viatris' investor-relations page lists the release of third-quarter 2026 financial results for Thursday, November 5, at 8:30 a.m. Eastern time. The announcement will give investors a fresh update on operating performance and management's outlook. The schedule is stated on the Viatris investor-relations page.
Viatris' latest listed corporate news includes the October 30 announcement that it had commenced a tender offer to acquire Pacira BioSciences. The transaction would expand the company's position in non-opioid pain therapies, while the results release will provide the next scheduled company update.
Investors can follow the real-time quote of Viatris stock for further intraday movements.
Viatris stock at a glance
- Company: Viatris Inc.
- ISIN: US92556V1061
- U.S. ticker: VTRS
- Lang & Schwarz quote: 16.63 euros at 13:37 Berlin time on Tuesday, November 3, 2026
Broader market developments can be followed through the S&P 500 market overview.
For further company news and analysis, see More news and analyses on Viatris stock.
